165 related articles for article (PubMed ID: 34136486)
1. Integrative Analysis of DNA Methylation and Transcriptome Identifies a Predictive Epigenetic Signature Associated With Immune Infiltration in Gliomas.
Zhang J; Yin J; Luo L; Huang D; Zhai D; Wang G; Xu N; Yang M; Song Y; Zheng G; Zhang Q
Front Cell Dev Biol; 2021; 9():670854. PubMed ID: 34136486
[TBL] [Abstract][Full Text] [Related]
2. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
Front Genet; 2022; 13():1053263. PubMed ID: 36712869
[No Abstract] [Full Text] [Related]
3. Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma.
Wang M; Zhou Z; Zheng J; Xiao W; Zhu J; Zhang C; Jiang X
Front Oncol; 2021; 11():650153. PubMed ID: 34055619
[TBL] [Abstract][Full Text] [Related]
4. Multi-Omics Data Integration Analysis of an Immune-Related Gene Signature in LGG Patients With Epilepsy.
Cheng Q; Duan W; He S; Li C; Cao H; Liu K; Ye W; Yuan B; Xia Z
Front Cell Dev Biol; 2021; 9():686909. PubMed ID: 34336837
[TBL] [Abstract][Full Text] [Related]
5. CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas.
Liu L; Yang Y; Duan H; He J; Sun L; Hu W; Zeng J
Front Oncol; 2021; 11():611038. PubMed ID: 33937022
[TBL] [Abstract][Full Text] [Related]
6. Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer.
Liu J; Ji C; Wang Y; Zhang C; Zhu H
Cancer Cell Int; 2021 Jul; 21(1):365. PubMed ID: 34246261
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of HDAC Family Identifies
Fan Y; Peng X; Wang Y; Li B; Zhao G
Front Mol Biosci; 2021; 8():720020. PubMed ID: 34540896
[No Abstract] [Full Text] [Related]
8. Comprehensive analysis of multi-omics data of recurrent gliomas identifies a recurrence-related signature as a novel prognostic marker.
Wang QW; Zhao Z; Bao ZS; Jiang T; Zhu YJ
Am J Cancer Res; 2021; 11(4):1226-1246. PubMed ID: 33948355
[TBL] [Abstract][Full Text] [Related]
9. LGALS3 Is a Poor Prognostic Factor in Diffusely Infiltrating Gliomas and Is Closely Correlated With CD163+ Tumor-Associated Macrophages.
Hu WM; Yang YZ; Zhang TZ; Qin CF; Li XN
Front Med (Lausanne); 2020; 7():182. PubMed ID: 32528967
[No Abstract] [Full Text] [Related]
10. Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma.
Hu X; Martinez-Ledesma E; Zheng S; Kim H; Barthel F; Jiang T; Hess KR; Verhaak RGW
Neuro Oncol; 2017 Jun; 19(6):786-795. PubMed ID: 28340142
[TBL] [Abstract][Full Text] [Related]
11. Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas.
Zeng WJ; Yang YL; Liu ZZ; Wen ZP; Chen YH; Hu XL; Cheng Q; Xiao J; Zhao J; Chen XP
Cell Physiol Biochem; 2018; 47(1):428-439. PubMed ID: 29794476
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas.
Song LR; Weng JC; Huo XL; Wang L; Li H; Li D; Wu Z; Zhang JT
J Neurooncol; 2020 Jan; 146(1):207-217. PubMed ID: 31853837
[TBL] [Abstract][Full Text] [Related]
13. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
[TBL] [Abstract][Full Text] [Related]
14. Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
Chai RC; Zhang KN; Chang YZ; Wu F; Liu YQ; Zhao Z; Wang KY; Chang YH; Jiang T; Wang YZ
Carcinogenesis; 2019 Oct; 40(10):1229-1239. PubMed ID: 31157866
[TBL] [Abstract][Full Text] [Related]
15. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
Front Immunol; 2020; 11():603341. PubMed ID: 33363544
[TBL] [Abstract][Full Text] [Related]
16. A novel tailored immune gene pairs signature for overall survival prediction in lower-grade gliomas.
Pan X; Wang Z; Liu F; Zou F; Xie Q; Guo Y; Shen L
Transl Oncol; 2021 Jul; 14(7):101109. PubMed ID: 33946034
[TBL] [Abstract][Full Text] [Related]
17. Integrated genomic, transcriptomic, and epigenetic analyses identify a leukotriene synthesis-related M2 macrophage gene signature that predicts prognosis and treatment vulnerability in gliomas.
Ji H; Liu Z; Wang N; Jin J; Zhang J; Dong J; Wang F; Yan X; Gong Q; Zhao H; Sun H; Li Y; Hu S; You C
Front Immunol; 2022; 13():970702. PubMed ID: 36159811
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive value of an immune infiltration signature in diffuse lower-grade gliomas.
Song LR; Weng JC; Li CB; Huo XL; Li H; Hao SY; Wu Z; Wang L; Li D; Zhang JT
JCI Insight; 2020 Mar; 5(8):. PubMed ID: 32229719
[TBL] [Abstract][Full Text] [Related]
19. Heme Oxygenase-1 Predicts Risk Stratification and Immunotherapy Efficacy in Lower Grade Gliomas.
Ye W; Liu Z; Liu F; Luo C
Front Cell Dev Biol; 2021; 9():760800. PubMed ID: 34858984
[No Abstract] [Full Text] [Related]
20. Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.
Li X; Wen D; Li X; Yao C; Chong W; Chen H
Front Immunol; 2020; 11():1678. PubMed ID: 33013820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
